Notes
2015 euros
Reference
Hunt B, et al. Modeling the Long-Term Cost-Effectiveness of IDegLira in Patients with Type 2 Diabetes Who are Failing To Meet Glycemic Targets on Basal Insulin Alone in The Netherlands. Diabetes Therapy 8: 753-765, No. 4, Aug 2017. Available from: URL: http://doi.org/10.1007/s13300-017-0266-3
Rights and permissions
About this article
Cite this article
IDegLira cost effective for T2DM uncontrolled on basal insulin. PharmacoEcon Outcomes News 785, 17 (2017). https://doi.org/10.1007/s40274-017-4267-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4267-2